Notification That Annual Report Will Be Submitted Late (nt 10-k)
March 31 2021 - 12:49PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
12b-25
Commission
File Number 000-55575
NOTIFICATION
OF LATE FILING
(Check
One): [X] Form 10-K [ ] Form 20-F [ ] Form
11-K [ ] Form 10-Q [ ] Form N-SAR
[ ] Form N-CSR
For
Period Ended: December 31, 2020
[ ] |
Transition
Report on Form 10-K |
[ ] |
Transition
Report on Form 20-F |
[ ] |
Transition
Report on Form 11-K |
[ ] |
Transition
Report on Form 10-Q |
[ ] |
Transition
Report on Form N-SAR |
For
Transition Period Ended:
__________________________
Nothing
in this form shall be construed to imply that the Commission has
verified any information contained herein.
If
the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates:
PART
I - REGISTRANT INFORMATION |
Full
Name of Registrant: Sigyn Therapeutics, Inc.
Former
Name if Applicable:
____________________________________________________________
Address
of Principal Executive Office (Street and
Number):
8880
Rio San Diego Drive
Suite
800
San Diego, CA 92108
PART
II - RULE 12B-25(B) AND (C) |
If
the subject report could not be filed without unreasonable effort
or expense and the registrant seeks relief pursuant to Rule
12b-25(b), the following should be completed. (Check box if
appropriate.)
[X] |
(a) |
The
reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or
expense; |
|
|
|
[X] |
(b) |
The
subject annual report, semi-annual report, transition report on
Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or
portion thereof, will be filed on or before the fifteenth calendar
day following the prescribed due date; or the subject quarterly
report or transition report on Form 10-Q or subject distribution
report on Form 10-D, or portion thereof, will be filed on or before
the fifth calendar day following the prescribed due date;
and
|
|
(c) |
The
accountant’s statement or other exhibit required by Rule 12b-25(c)
has been attached if applicable. |
State
below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D,
N-SAR, N-CSR, or the transition report or portion thereof, could
not be filed within the prescribed time period.
The
Registrant’s Annual Report on Form 10-K for the year ended December
31, 2020 cannot be filed within the prescribed time period because
the Registrant is experiencing unexpected delays in the collection
and compilation of certain information required to be included in
the Form 10-K. The Registrant’s Annual Report on Form 10-K will be
filed on or before the fifteenth calendar day following the
prescribed due date.
PART
IV - OTHER INFORMATION |
(1) |
Name
and telephone number of person to contact in regard to this
notification: |
|
Jolie
Kahn |
|
011-972 |
|
215-375-6646 |
|
(Name) |
|
(Area
Code) |
|
(Telephone
Number) |
(2) |
Have
all other periodic reports required under Section 13 or 15(d) of
the Securities Exchange Act of 1934 or Section 30 of the Investment
Company Act of 1940 during the preceding 12 months or for such
shorter period that the registrant was required to file such
report(s) been filed ? If answer is no, identify
report(s). |
[X]
Yes [ ] No
(3) |
Is it
anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject
report or portion thereof? |
[ ]
Yes [X] No
If
so, attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the
reasons why a reasonable estimate of the results cannot be
made.
Sigyn Therapeutics, Inc.
(Name
of Registrant as specified in charter)
has
caused this notification to be signed on its behalf by the
undersigned thereunto duly authorized.
Date:
March 31, 2021 |
By: |
/s/
Jim Joyce |
|
Name: |
Jim
Joyce |
|
Title: |
Chief
Executive Officer |
Sigyn Therapeutics (PK) (USOTC:SIGY)
Historical Stock Chart
From Apr 2022 to May 2022
Sigyn Therapeutics (PK) (USOTC:SIGY)
Historical Stock Chart
From May 2021 to May 2022